Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FHQ6P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,171
Award facts
- Contract value 100% obligated
- $18,171.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,171.41 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector medication. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued on December 15, 2025, with an ultimate completion date of December 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026, which authorizes the company to supply pharmaceutical products and medical supplies globally to support military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Repatha is a PCSK9 inhibitor used for managing high cholesterol in patients with cardiovascular disease, and this delivery order represents one of numerous competitive awards under the DLA's pharmaceutical supply chain. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse medical supply requirements through open competition, ranging from small-value transactions to substantial orders, positioning it as a key supplier for military and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DR26FHQ6P?
SPE2DR26FHQ6P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FHQ6P worth?
The government has obligated $18,171 on SPE2DR26FHQ6P.
Is contract SPE2DR26FHQ6P an order under another contract?
Yes. SPE2DR26FHQ6P is a delivery order under SPE2DR25D1041, an indefinite delivery contract.
Was contract SPE2DR26FHQ6P competed?
The extent of competition for SPE2DR26FHQ6P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award